Stay updated with breaking news from Nasdaq Rani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Stock analysts at Zacks Small Cap increased their FY2024 earnings per share estimates for Rani Therapeutics in a research note issued to investors on Thursday, March 21st. Zacks Small Cap analyst J. Vandermosten now expects that the company will post earnings per share of ($1.00) for […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Zacks Small Cap raised their FY2024 earnings per share (EPS) estimates for shares of Rani Therapeutics in a research note issued on Thursday, March 21st. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will post earnings of ($1.00) per share for the year, […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Equities researchers at Wedbush decreased their FY2027 earnings per share (EPS) estimates for Rani Therapeutics in a research note issued to investors on Tuesday, February 6th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings of ($1.78) per share for the year, down […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) CEO Talat Imran acquired 5,000 shares of the stock in a transaction on Monday, December 4th. The stock was purchased at an average cost of $2.57 per share, with a total value of $12,850.00. Following the transaction, the chief executive officer now directly owns 474,455 shares […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) CEO Talat Imran purchased 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was acquired at an average price of $2.05 per share, for a total transaction of $41,000.00. Following the acquisition, the chief executive officer now directly […]